“Choose France”, argued the government on Monday, facing the bosses of large companies gathered in Versailles for the annual summit on the attractiveness of the country. “Stay there and invest in it,” he added Tuesday afternoon at the Elysee Palace for pharmaceutical companies. Emmanuel Macron welcomed their representatives within the framework of the Strategic Council of Health Industries (CSIS), the first since 2018. The opportunity to renew the growth and trust pact with the State, and to announce 7 billion euros euros of credits for the sector haloed by its role in the fight against Covid.
Such sums had never been aligned at the end of a CSIS: 1.5 billion for university hospital research (IHU and RHU), 2 billion for investment in health via bpifrance, 1.5 billion to help to the relocation of industrial projects, and 2 billion to accelerate investment in three sectors of the future. This program draws heavily on the program of investments for the future, even if some measures are financed through the annual budget of the Health Insurance (Ondam).